As of the latest Form 4 filed Jun 12, 2026.
What Myriad Genetics Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 48 most recent filings for MYGN.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | 2026-06-11 | Donnelly Brian J Chief Commerical Officer | AAward | +5.00K | $3.94 | $19.7K | No | Form 4 ↗ |
| 2026-06-12 | 2026-06-11 | Raha Samraat S. President and CEO | AAward | +3.54K | $3.94 | $13.9K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Kumar Rashmi Director | SSale | −15.0K | $4.46 | $66.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Davis Mark Steven Director | AAward | +59.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Kumar Rashmi Director | AAward | +59.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Newcomer Lee Nisley Director | AAward | +59.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Reitan Colleen F Director | AAward | +59.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Skovronsky Daniel Director | AAward | +59.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Phanstiel S. Louise Director | AAward | +59.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Dreismann Heinrich Director | AAward | +59.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Bisaro Paul Director | AAward | +59.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-06-01 | Jampa Raj Chief Technology Officer | AAward | +252K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-14 | 2026-05-14 | Bisaro Paul Director | PPurchase | +7.50K | $3.69 | $27.6K | No | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | Donnelly Brian J Chief Commerical Officer | FTax | −56.0K | $4.80 | $269K | No | Form 4 ↗ |
| 2026-04-15 | 2026-04-14 | Muzzey Dale Chief Scientific Officer | FTax | −946.00 | $4.91 | $4.64K | No | Form 4 ↗ |
| 2026-04-15 | 2026-04-14 | Verratti Mark Chief Operating Officer | FTax | −1.07K | $4.91 | $5.25K | No | Form 4 ↗ |
| 2026-03-23 | 2026-03-22 | Wheeler Benjamin Richard Chief Financial Officer | FTax | −549.00 | $4.58 | $2.51K | No | Form 4 ↗ |
| 2026-03-23 | 2026-03-22 | Muzzey Dale Chief Scientific Officer | FTax | −2.02K | $4.58 | $9.25K | No | Form 4 ↗ |
| 2026-03-23 | 2026-03-22 | Verratti Mark Chief Operating Officer | FTax | −2.06K | $4.58 | $9.41K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-15 | Wheeler Benjamin Richard Chief Financial Officer | FTax | −2.19K | $4.66 | $10.2K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-15 | Wheeler Benjamin Richard, Chief Financial Officer | FTax | −877.00 | $4.66 | $4.09K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-15 | Muzzey Dale Chief Scientific Officer | FTax | −11.9K | $4.66 | $55.7K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-15 | Muzzey Dale, Chief Scientific Officer | FTax | −4.78K | $4.66 | $22.3K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-15 | Haas Kevin Richard Chief Technology Officer | FTax | −8.38K | $4.66 | $39.1K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-15 | Haas Kevin Richard, Chief Technology Officer | FTax | −3.35K | $4.66 | $15.6K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-15 | Verratti Mark Chief Operating Officer | FTax | −9.10K | $4.66 | $42.4K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-15 | Verratti Mark, Chief Operating Officer | FTax | −5.61K | $4.66 | $26.1K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-14 | Wheeler Benjamin Richard Chief Financial Officer | FTax | −1.10K | $4.66 | $5.11K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-14 | Muzzey Dale Chief Scientific Officer | FTax | −8.29K | $4.66 | $38.6K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-14 | Haas Kevin Richard Chief Technology Officer | FTax | −4.16K | $4.66 | $19.4K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-14 | Raha Samraat S. President and CEO | FTax | −10.8K | $4.66 | $50.4K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-14 | Verratti Mark Chief Operating Officer | FTax | −5.42K | $4.66 | $25.2K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-14 | Solaiman Shereen Chief People Officer | FTax | −5.78K | $4.66 | $27.0K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Wheeler Benjamin Richard Chief Financial Officer | FTax | −586.00 | $4.66 | $2.73K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Muzzey Dale Chief Scientific Officer | FTax | −12.8K | $4.66 | $59.6K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Fox Jennifer Lynne Chief Legal Officer | FTax | −6.00K | $4.66 | $27.9K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Haas Kevin Richard Chief Technology Officer | FTax | −6.41K | $4.66 | $29.9K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Raha Samraat S. President and CEO | FTax | −36.3K | $4.66 | $169K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Verratti Mark Chief Operating Officer | FTax | −9.16K | $4.66 | $42.7K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Solaiman Shereen Chief People Officer | FTax | −8.90K | $4.66 | $41.5K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Wheeler Benjamin Richard Chief Financial Officer | AAward | +206K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Donnelly Brian J Chief Commerical Officer | AAward | +227K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Muzzey Dale Chief Scientific Officer | AAward | +173K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Fox Jennifer Lynne Chief Legal Officer | AAward | +196K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Raha Samraat S. President and CEO | AAward | +619K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Verratti Mark Chief Operating Officer | AAward | +247K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Solaiman Shereen Chief People Officer | AAward | +173K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-09 | Raha Samraat S. President and CEO | PPurchase | +40.0K | $5.00 | $200K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also MYGN’s full analysis or the market-wide insider trading feed. The tabs above jump to MYGN’s other SEC data.
Source: SEC Form 4 filings for MYGN, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.